ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702759 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702759; 2) Community: the network communities that were significantly associated with the response to NSC 702759; 3) Molecule: the relationships between components within communities and NSC 702759; 4) MDR: the compounds that were significantly associated with the NSC 702759.

NSC Compound Enrichment Correlation
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0462077035966088 0.051653083
NSC 648365 Insulin-Methotrexate conjugate 0.0462077035966088 0.2126335
NSC 650012 Null 0.0462077035966088 -0.1901911
NSC 653547 Null 0.0462077035966088 -0.13204842
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.0462077035966088 0.042870219
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0462077035966088 0.04847263
NSC 668833 Null 0.0462077035966088 0.36307061
NSC 671865 Null 0.0462077035966088 -0.143723
NSC 671963 Null 0.0462077035966088 -0.22876002
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0462077035966088 -0.079374099
Total:82  Current:76    [First] [Prev] [Next] [Last]